Edition:
India

Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS)

600196.SS on Shanghai Stock Exchange

27.47CNY
19 Sep 2019
Change (% chg)

¥0.39 (+1.44%)
Prev Close
¥27.08
Open
¥27.26
Day's High
¥27.55
Day's Low
¥27.03
Volume
15,601,809
Avg. Vol
16,492,216
52-wk High
¥32.25
52-wk Low
¥20.61

Latest Key Developments (Source: Significant Developments)

Fosun International Says Final Offer Price Of Shanghai Henlius H Shares Is HK$49.60/ Share
Wednesday, 18 Sep 2019 

Sept 18 (Reuters) - Fosun International Ltd <0656.HK>::FINAL OFFER PRICE OF SHANGHAI HENLIUS H SHARES TO BE ISSUED UNDER GLOBAL OFFERING IS HK$49.60 PER SHANGHAI HENLIUS OFFER SHARE.IF GLOBAL OFFERING PROCEEDS AT FINAL OFFER PRICE, MARKET CAP OF SHANGHAI HENLIUS AFTER COMPLETION TO BE HK$26,740.8 MILLION.INTERNATIONAL UNDERWRITING AGREEMENT FOR INTERNATIONAL OFFERING ENTERED BY SHANGHAI HENLIUS AND UNDERWRITERS OF OFFERING.SHANGHAI HENLIUS IS EXPECTED TO BE LISTED ON MAIN BOARD OF HONG KONG STOCK EXCHANGE ON 25 SEPTEMBER.UNDER INTERNATIONAL AGREEMENT, UNDERWRITERS TO SUBSCRIBE FOR SHANGHAI HENLIUS OFFER SHARES AT HK$49.60 PER SHARE.  Full Article

Shanghai Fosun Pharma's Unit To Buy GlaxoSmithkline Pharmaceuticals (Suzhou)
Monday, 8 Jul 2019 

July 8 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK::SAYS UNIT SIGNS AGREEMENT TO BUY GLAXOSMITHKLINE PHARMACEUTICALS (SUZHOU) FOR UP TO 250.0 MILLION YUAN ($36.34 million).  Full Article

Shanghai Fosun Pharmaceutical's Unit Pays 579.6 Mln Yuan For Pharma Firm Stake
Friday, 5 Jul 2019 

July 5 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK::SAYS UNIT WINS BID FOR 54.8 MILLION SHARES IN PHARMA FIRM FOR 579.6 MILLION YUAN ($84.30 million).  Full Article

Shanghai Fosun Pharmaceutical Group Co Says Aohong Pharma And SDIC Gaoxin Enters Property Transaction Contract
Friday, 5 Jul 2019 

July 5 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>::AOHONG PHARMA AND SDIC GAOXIN ENTERED INTO PROPERTY TRANSACTION CONTRACT.AOHONG PHARMA PROPOSED TO ACQUIRE 54.8 MILLION SHARES IN TARGET COMPANY HELD BY SDIC GAOXIN AT RMB579.633 MILLION.  Full Article

Shanghai Fosun Pharmaceutical Says CQ Pharma Enters Framework Sales And Purchases Agreement
Friday, 5 Jul 2019 

July 5 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>::CQ PHARMA ENTERED AGREEMENT FOR SUPPLY OF SALES PRODUCTS AND PURCHASE OF PROCUREMENT PRODUCTS FOR A TERM OF 1 YEAR.CO AND FOSUN INTERNATIONAL ENTERED INTO MUTUAL SUPPLY FRAMEWORK AGREEMENT.UTUAL SUPPLY FRAMEWORK DEAL FOR MUTUAL SUPPLY OF PRODUCTS AND SERVICES BETWEEN GROUP AND FOSUN INTERNATIONAL FOR 1 YEAR.  Full Article

Shanghai Fosun Pharmaceutical's Unit Plans To Invest For Almost 98% Stake In Chengdu Medical Firm
Tuesday, 25 Jun 2019 

June 25 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK::SAYS ITS UNIT PLANS TO INVEST UP TO 746.7 MILLION YUAN ($108.55 million) IN ALMOST 98% STAKE IN CHENGDU MEDICAL FIRM.  Full Article

Shanghai Fosun Pharmaceutical's Q1 Net Profit Up 0.9 Percent Y/Y
Monday, 29 Apr 2019 

April 29 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>2196.HK::SAYS Q1 NET PROFIT UP 0.9 PERCENT Y/Y.  Full Article

BRIEF-Shanghai Fosun Pharmaceutical's Units Plan Project, Sign Licence Agreement With UK Firm
Tuesday, 9 Apr 2019 

Adds bullet point, link:SAYS UNIT PLANS BIO-PHARMA PROJECT WITH INVESTMENT OF UP TO 1.0 BILLION YUAN ($149.09 million).SAYS BOARD APPROVES UNIT TO SIGN LICENSE AGREEMENT WITH RENEURON LIMITED IN U.K..  Full Article

Reneuron Group Partners With Fosun Pharma In China
Tuesday, 9 Apr 2019 

April 9 (Reuters) - ReNeuron Group PLC ::RENEURON PARTNERS WITH FOSUN PHARMA IN CHINA.RENEURON TO RECEIVE UPFRONT, NEAR TERM AND ESTIMATED SUCCESS-BASED MILESTONE PAYMENTS OF £80.0 MILLION.FOSUN PHARMA WILL FULLY FUND DEVELOPMENT OF RENEURON'S CTX AND HRPC CELL THERAPY PROGRAMMES IN CHINA.RENEURON WILL ALSO RECEIVE TIERED ROYALTIES AT RATES BETWEEN 12% AND 14% ON SALES OF LICENSED PRODUCTS IN CHINESE MARKET.  Full Article

Shanghai Fosun Pharmaceutical Approved Proposed Issuance Of Corporate Bonds
Friday, 29 Mar 2019 

March 29 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd <600196.SS>::BOARD CONSIDERED AND APPROVED PROPOSED ISSUANCE OF CORPORATE BONDS.PROPOSED THAT SIZE OF PROPOSED ISSUANCE WILL NOT BE MORE THAN RMB10.0 BILLION.  Full Article